Pricing Log in Create free account

Allogene Therapeutics, Inc. (ALLO) vs Zura Bio Limited (ZURA)

Allogene Therapeutics, Inc. and Zura Bio Limited are both Biotechnology companies. Allogene Therapeutics, Inc. and Zura Bio Limited are of similar size ($376.6M and $358.3M). Zura Bio Limited has the higher net margin (0.00% vs −3,517.4%) and the higher return on invested capital (0.00% vs −108.8%). Across the 12 metrics below, Zura Bio Limited leads on 7 and Allogene Therapeutics, Inc. on 5.

Valuation

Metric ALLO ZURA Biotechnology median
P/E n/m n/m 10.60
P/S 72.71 n/m 9.40
P/B 0.78 2.95 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 2.02 n/m 9.02
Earnings yield (64.42%) (27.30%) (32.88%)
Free cash flow yield (29.99%) (16.52%) (23.13%)

Profitability

Metric ALLO ZURA Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (3,832.45%) 0.00% 0.00%
Net margin (3,517.41%) 0.00% 0.00%
Free cash flow margin (2,180.62%) 0.00% 0.00%
Return on equity (42.39%) (85.05%) (51.96%)
Return on assets (32.43%) (72.21%) (46.06%)
Return on invested capital (108.81%) 0.00% 0.00%

Growth

Metric ALLO ZURA Biotechnology median
Revenue growth (TTM) 7,613.11% — 6.76%
EPS growth (last fiscal year) 34.09% (76.67%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALLO ZURA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 10.72 11.29 4.97
Net debt to EBITDA 1.24 1.45 1.01

Dividend

Metric ALLO ZURA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALLO ZURA Biotechnology median
Market cap 376.58m 358.33m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack